Vanguard Group Inc
- SEC CIK
- 0000102909
- Latest filing
- Jan 29, 2026
NAMS holding history
NewAmsterdam Pharma Co N.V. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NAMS overviewAll 13F holders of NAMSFull Q4 2025 holdings
- Shares (Q4 2025)
- 172,956
- Value
- $6.07M
- % of portfolio
- <0.1%
- Quarters held
- 7
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 172,956 | $6.07M | <0.1% | +490+0.3% | Added | Holders |
| Q3 2025 | 172,466 | $4.90M | <0.1% | −6,380−3.6% | Reduced | Holders |
| Q2 2025 | 178,846 | $3.24M | <0.1% | +148,370+486.8% | Added | Holders |
| Q1 2025 | 30,476 | $623.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 30,476 | $783.2K | <0.1% | +17,031+126.7% | Added | Holders |
| Q3 2024 | 13,445 | $223.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 13,445 | $258.3K | <0.1% | +13,445 | New | Holders |